FdaApplication
ANDA 216206
Identifiers
- fda_app_no: ANDA216206
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2022-07-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 3MG/3ML (1MG/ML) | SOLUTION;INTRAVENOUS |
1 product